Premium
ENDOSCOPIC MANAGEMENT OF BILIOCUTANEOUS FISTULA AFTER PERCUTANEOUS RADIOFREQUENCY ABLATION THERAPY FOR HEPATOCELLULAR CARCINOMA
Author(s) -
Tsujino Takeshi,
Sasahira Naoki,
Hirano Kenji,
Tateishi Ryosuke,
Isayama Hiroyuki,
Tada Minoru,
Shiina Shuichiro,
Yoshida Haruhiko,
Kawabe Takao,
Omata Masao
Publication year - 2010
Publication title -
digestive endoscopy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.5
H-Index - 56
eISSN - 1443-1661
pISSN - 0915-5635
DOI - 10.1111/j.1443-1661.2009.00918.x
Subject(s) - medicine , hepatocellular carcinoma , percutaneous , fistula , cirrhosis , radiofrequency ablation , bile duct , surgery , radiology , gastroenterology , ablation
Our patient was a 70‐year‐old man with hepatocellular carcinoma (HCC) and liver cirrhosis (Child–Pugh B). He had a history of distal gastrectomy with Billroth II reconstruction for duodenal ulcer and hepatectomy for HCC. One month after percutaneous radiofrequency ablation (RFA) for recurrent HCC, biliocutaneous fistula was observed. The cholangiogram demonstrated leakage of contrast material from an intrahepatic duct into the fistula, and a nasobiliary catheter was placed. Subsequently, the discharge of bile steadily decreased and stopped. Follow‐up cholangiogram revealed no evidence of bile leakage. Biliocutaneous fistula is an extremely rare complication after percutaneous RFA, and the present case report suggests that endoscopic drainage is the first‐line therapy for bile leaks after RFA.